Literature DB >> 21441474

Virus-host interactions in HIV pathogenesis: directions for therapy.

J A Levy1.   

Abstract

The challenge of controlling HIV infection involves an understanding of the heterogeneity of the virus, its wide cellular host range, its primary routes of transmission, and the immunologic and intrinsic cellular factors that can prevent its transmission and replication. Identification of HIV-infected individuals who have survived more than 10 years without signs of the infection and without therapy encourages studies examining the natural mechanisms for resistance to infection and disease. Within the immune system, emphasis should be given to the innate or natural response that appears within minutes of the infection and offers the optimal time for controlling HIV. All these parameters in HIV pathogenesis underline the information needed to develop optimal anti-HIV therapies and an effective AIDS vaccine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21441474      PMCID: PMC3144039          DOI: 10.1177/0022034511398874

Source DB:  PubMed          Journal:  Adv Dent Res        ISSN: 0895-9374


  41 in total

1.  HIV-1 nomenclature proposal.

Authors:  D L Robertson; J P Anderson; J A Bradac; J K Carr; B Foley; R K Funkhouser; F Gao; B H Hahn; M L Kalish; C Kuiken; G H Learn; T Leitner; F McCutchan; S Osmanov; M Peeters; D Pieniazek; M Salminen; P M Sharp; S Wolinsky; B Korber
Journal:  Science       Date:  2000-04-07       Impact factor: 47.728

Review 2.  Understanding the genetic diversity of HIV-1.

Authors:  F E McCutchan
Journal:  AIDS       Date:  2000       Impact factor: 4.177

Review 3.  Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials.

Authors:  Martine Peeters; Coumba Toure-Kane; John N Nkengasong
Journal:  AIDS       Date:  2003-12-05       Impact factor: 4.177

4.  Origins. On the origin of the immune system.

Authors:  John Travis
Journal:  Science       Date:  2009-05-01       Impact factor: 47.728

5.  Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection.

Authors:  B Asjö; L Morfeldt-Månson; J Albert; G Biberfeld; A Karlsson; K Lidman; E M Fenyö
Journal:  Lancet       Date:  1986-09-20       Impact factor: 79.321

Review 6.  The importance of the innate immune system in controlling HIV infection and disease.

Authors:  J A Levy
Journal:  Trends Immunol       Date:  2001-06       Impact factor: 16.687

7.  Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients.

Authors:  V Soumelis; I Scott; F Gheyas; D Bouhour; G Cozon; L Cotte; L Huang; J A Levy; Y J Liu
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

8.  Interferon-alpha generation and immune reconstitution during antiretroviral therapy for human immunodeficiency virus infection.

Authors:  F P Siegal; P Fitzgerald-Bocarsly; B K Holland; M Shodell
Journal:  AIDS       Date:  2001-09-07       Impact factor: 4.177

9.  Increased in vitro cytopathicity of CC chemokine receptor 5-restricted human immunodeficiency virus type 1 primary isolates correlates with a progressive clinical course of infection.

Authors:  David Kwa; Jose Vingerhoed; Brigitte Boeser; Hanneke Schuitemaker
Journal:  J Infect Dis       Date:  2003-04-09       Impact factor: 5.226

Review 10.  The search for the CD8+ cell anti-HIV factor (CAF).

Authors:  Jay A Levy
Journal:  Trends Immunol       Date:  2003-12       Impact factor: 16.687

View more
  10 in total

1.  HIV-1 Nef CAWLEAQ motif: a regulator of monocytes invasion through ENO1 modulation.

Authors:  Reshu Saxena; Umesh Kumar Vekariya; Pradeep Kumar; Amit Kumar Tripathi; Jimut Kanti Ghosh; Raj Kamal Tripathi
Journal:  Mol Cell Biochem       Date:  2018-02-05       Impact factor: 3.396

2.  Human Immunodeficiency Virus (HIV).

Authors: 
Journal:  Transfus Med Hemother       Date:  2016-05-09       Impact factor: 3.747

Review 3.  Updating on Roles of HIV Intrinsic Factors: A Review of Their Antiviral Mechanisms and Emerging Functions.

Authors:  Sudarat Hadpech; Sutpirat Moonmuang; Koollawat Chupradit; Umpa Yasamut; Chatchai Tayapiwatana
Journal:  Intervirology       Date:  2021-08-31       Impact factor: 2.294

4.  Late-emerging strains of HIV induce T-cell homeostasis failure by promoting bystander cell death and immune exhaustion in naïve CD4 and all CD8 T-cells.

Authors:  Catherine N Kibirige; Frederick A Menendez; Hao Zhang; Tricia L Nilles; Susan Langan; Joseph B Margolick
Journal:  Med Hypotheses       Date:  2014-04-13       Impact factor: 1.538

5.  Natural antimicrobial peptides as promising anti-HIV candidates.

Authors:  Guangshun Wang
Journal:  Curr Top Pept Protein Res       Date:  2012

6.  Impact of viral factors on subcellular distribution and RNA export activity of HIV-1 rev in astrocytes 1321N1.

Authors:  Atoshi Banerjee; Ronald Benjamin; Sharmistha Banerjee
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

7.  Immune Activations and Viral Tissue Compartmentalization During Progressive HIV-1 Infection of Humanized Mice.

Authors:  Hang Su; Yan Cheng; Sruthi Sravanam; Saumi Mathews; Santhi Gorantla; Larisa Y Poluektova; Prasanta K Dash; Howard E Gendelman
Journal:  Front Immunol       Date:  2019-02-28       Impact factor: 7.561

Review 8.  Peptide entry inhibitors of enveloped viruses: the importance of interfacial hydrophobicity.

Authors:  Hussain Badani; Robert F Garry; William C Wimley
Journal:  Biochim Biophys Acta       Date:  2014-04-26

9.  Reactivation of latent HIV-1 in vitro using an ethanolic extract from Euphorbia umbellata (Euphorbiaceae) latex.

Authors:  Ana Luiza Chaves Valadão; Paula Pezzuto; Viviane A Oliveira Silva; Barbara Simonson Gonçalves; Átila Duque Rossi; Rodrigo Delvecchio da Cunha; Antonio Carlos Siani; João Batista de Freitas Tostes; Marcelo Trovó; Paulo Damasco; Gabriel Gonçalves; Rui Manuel Reis; Renato Santana Aguiar; Cleonice Alves de Melo Bento; Amilcar Tanuri
Journal:  PLoS One       Date:  2018-11-27       Impact factor: 3.240

10.  Avirulins, a Novel Class of HIV-1 Reverse Transcriptase Inhibitors Effective in the Female Reproductive Tract Mucosa.

Authors:  Michelle D Cherne; Jesse Hall; Alisha Kellner; Christine F Chong; Amy L Cole; Alexander M Cole
Journal:  Viruses       Date:  2019-05-01       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.